Literature DB >> 23228977

Serum uric acid level is an independent risk factor for presence of calcium in coronary arteries: an observational case-controlled study.

Aslı Inci Atar1, Omer Cağlar Yılmaz, Kayıhan Akın, Yusuf Selçoki, Okan Er, Beyhan Eryonucu.   

Abstract

OBJECTIVE: A link between uric acid levels and cardiovascular diseases has been previously reported. Coronary artery calcium score (CACS) is a marker of atherosclerotic disease and a predictor of cardiovascular events. We sought to determine if serum uric acid level is an independent risk factor for the presence of calcium in coronary arteries.
METHODS: Four hundred and forty-two patients who were evaluated in the cardiology outpatient clinic for suspected coronary heart disease with a low-moderate risk for coronary artery disease were included in this observational case-controlled study. Serum uric acid levels were measured with colorimetric methods. CACS were performed using a 64-slice CT scanner. Patients were divided to 3 groups according to their CACS value (Group 1: CACS=0, Group 2: CACS 1-100, Group 3: CACS>100).
RESULTS: The demographical characteristics and laboratory findings of 3 groups were similar, except age, fasting glucose levels and serum uric acid levels. Serum uric acid levels were found to increase significantly with increasing CACS (p=0.001). Patients were grouped according to presence CAC (CACS=0 and CACS≥1) and in the multiple regression analysis, age (OR, 1.11, 95% CI, 1.07-1.16), smoking (OR, 3.83, 95% CI, 2.06-7.09), serum uric acid levels (OR, 1.26, 95% CI, 1.04-1.54) and average 10-year total risk of Framingham risk score (OR, 1.13, 95% CI, 1.04-1.09) appeared as independent factors predictive of presence of CAC (p<0.05).
CONCLUSION: Serum uric acid level is an independent risk factor for presence of coronary calcium. Moreover, increasing levels of serum uric acid are associated with increasing CACS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23228977     DOI: 10.5152/akd.2013.039

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  7 in total

1.  Association Between Gout and Aortic Stenosis.

Authors:  Kevin Chang; Chio Yokose; Craig Tenner; Cheongeun Oh; Robert Donnino; Alana Choy-Shan; Virginia C Pike; Binita D Shah; Jeffrey D Lorin; Svetlana Krasnokutsky; Steven P Sedlis; Michael H Pillinger
Journal:  Am J Med       Date:  2016-10-06       Impact factor: 4.965

Review 2.  Hyperuricemia, Cardiovascular Disease, and Hypertension.

Authors:  Masanari Kuwabara
Journal:  Pulse (Basel)       Date:  2016-03-12

Review 3.  Diabetes and Hypertension Consistently Predict the Presence and Extent of Coronary Artery Calcification in Symptomatic Patients: A Systematic Review and Meta-Analysis.

Authors:  Rachel Nicoll; Ying Zhao; Pranvera Ibrahimi; Gunilla Olivecrona; Michael Henein
Journal:  Int J Mol Sci       Date:  2016-09-06       Impact factor: 5.923

4.  The association between hyperuricemia and coronary artery calcification development: A systematic review and meta-analysis.

Authors:  Ling Liang; Xianghua Hou; Kevin R Bainey; Yanlin Zhang; Wayne Tymchak; Zhongquan Qi; Weihua Li; Hoan Linh Banh
Journal:  Clin Cardiol       Date:  2019-09-30       Impact factor: 2.882

5.  Cardiac structural and functional abnormalities in primary hyperparathyroidism.

Authors:  S Purra; A A Lone; M H Bhat; R A Misgar; A I Wani; M I Bashir; S R Masoodi; W Purra
Journal:  J Endocrinol Invest       Date:  2021-07-29       Impact factor: 4.256

6.  Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot.

Authors:  Panagiota Drivelegka; Helena Forsblad-d'Elia; Oskar Angerås; Göran Bergström; Caroline Schmidt; Lennart T H Jacobsson; Mats Dehlin
Journal:  Arthritis Res Ther       Date:  2020-02-22       Impact factor: 5.156

7.  Serum uric acid is associated with coronary artery calcification.

Authors:  Chagai Grossman; Joseph Shemesh; Nira Koren-Morag; Gil Bornstein; Ilan Ben-Zvi; Ehud Grossman
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-16       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.